Don't miss the triennial congress of EFIC taking place in Istanbul 13-16 September 2006. For further details visit the congress website at: www.kenes.com/efic. Meeting has full CME accreditation (18 points).

  • Abstract submission is now open online at www.kenes.com/efic . Deadline for abstract submission is May 15, 2006 .
  • Each full registration will receive a free three year subscription to EFIC´s official journal “the European Journal of Pain”. For further information for full registration and this offer, consult the preliminary announcement of the congress.

  • The Congress has a “Financial Aid” form available for applicants from low resource and currency restricted countries. The Financial Application details can be found at: http://www.kenes.com/efic/fin_deadline.asp


For further details on the congress and Istanbul , visit the appropriate page on this site or the above website reference.





Thursday,
September 14, 2006

Friday,
September 15, 2006

Saturday,
September 16, 2006

09:00-10:30 Plenary Sessions

p1

Training the body and the brain: Current concepts in rehabilitation. 
G. Lorimer Moseley , UK

The science of fear: mechanisms and management of catastrophising
Michael J.L. Sullivan , Canada

Special needs for pain management in the elderly
Robert Helme , Australia

p2

Painful peripheral neuropathies
Steve Scherer , USA

 

Anti- TNFa therapies for pain: the science and clinical results
Rob J. Moots , UK          

Painful neuropathy following cancer chemotherapy
Gary Bennett , Canada

p3

Imaging pain
Irene Tracey , UK

Gene expression microarrays in the discovery of pain mechanisms
Michael Costigan , USA

Morphine analgesia without constipation: peripheralized opiate receptor antagonists
Eric Carter , USA

11:00-12:30 Topical Seminars (Parallel Sessions)

TS1

Free communications 1

Free communications 2

Free communications 3

TS2

Central hypersensitivity in chronic musculo­skeletal & visceral pain
Lars Arendt-Nielsen , Denmark    
Tony Dickenson , UK
Maria Adele Giamberardi , Italy

Visceral pain – basic and clinical aspects
Maria Adele Giamberardino , Italy  
Ursula Wesselman , USA
Karen Berkley , USA

Pediatric pain: effects now and later in life
Dick Tibboel , The Netherlands
Karel Allegaert , Belgium
Christiane Hermann , Germany

TS3

Pathophysiology and therapy of orofacial pain. 
Joanna Zakrzewska , UK
Yair Sharav , Israel
Turo Nurmikko , UK

Small fiber neuropathies – what makes them painful?
Ellen Jorum , Norway
Torhild Warncke , Norway
Claudia Sommer , Germany
Kristin Ørstavik , Norway

Epidemiology of chronic pain and its impact on health care systems
Rolf-Detlef Treede , Germany
Reinhard Thoma , Germany
Franco Mongini , Italy
Thomas R. Toelle , Germany

TS4

Spinal injections for pain control:  what is the evidence?    
Serdar Erdine , Turkey
Samuel Hassenbusch , USA
Ben Crul , The Netherlands
Gul Talu , Turkey

Migraine genes and mechanisms: three painful questions
Michel Ferrari , The Netherlands
Rami Burstein , USA
Peter Goadsby , UK

Non-neural cells, receptor sensiti­zation and central sensitization
Allan Basbaum , USA
Steve McMahon , UK
Christoph Stein , Germany
Maria Fitzgerald , UK

TS5

Role of cerebral cortex in pain perception
Marc Sindou , France
Patrick Mertens , France
Roland Peyron , France

 

Anti-inflammatory cytokines (IL-10, thalidomide?) for pain therapy?
Linda Watkins , USA   
Don Manning , USA
Kirk Johnson , USA

AMPA- & NMDA-type glutamate receptors and their protein-protein interactions in pain processing
Susan Fleetwood-Walker , UK
Rohini Kuner , Germany
Volker Neugebauer , USA

TS6

Cox-2-inhibitors: New insights, new options?
Kay Brune , Germany        
Hanns Ulrich Zeilhofer , Switzerland
Karsten Schroer , Germany

Measuring the placebo effect, drugs that enhance it, and lessons for clinical trial methodology
Fabrizio Benedetti , Italy
Predrag Petrovic , Sweden
Lene Vase , Denmark

Nurse prescribing and the role of nurses in pain management 
Kate Seers , UK
Trudy Towell , UK
Tone Rustøen , Norway

TS7

Programming specificity: the potential of siRNAs, gene therapy, and antibodies as pain relief strategies of the future.
Martin Koltzenburg , UK
TBA
TBA

Does physiotherapy have efficacy for low back pain?  The evidence
Maureen Simmonds , Canada
Jennifer Klaber Moffet , UK
Harriet Wittink
, The Netherlands

Cues for pain and distress from others
Geert Crombez , Belgium   
Liesbet Goubert , Belgium
Jeff Mogil , Canada
Gwenola Herbette , Belgium

14:30-16:00 Topical Seminars (Parallel Sessions)

TS8

Clinical case discussion:  Chronic pain – does neuropathic pain differ from inflammatory pain and does it matter ?
Nadine Attal , France
Thomas Toelle , Germany

Clinical case discussion:Should patients under chronic opioid and/or anticonvulsant therapy drive their car?
Klaus Lehmann , Germany
Rainer Sabatowski , Germany

Clinical case discussion: Opioids for patients with non-cancer pain.
Henry McQuay , UK
Ben Crul , The Netherlands

TS9

Nerve inflammation as a factor in neuropathic and cancer related pain
Eli Eliav , Israel
Gary Bennett , Canada
Claudia Sommer , Germany

Foraminal (pulsed) radiofrequency technique: does it relieve pain, and how?  
Jan Van Zundert , Belgium
Bert Joosten , The Netherlands
Alex Cahana , Switzerland

Practical considerations in interventional pain management at the end of life.
Stein Kaasa , Norway
Harald Breivik , Norway
Luchas Radbruch , Germany

TS10

Cannabinoids in pain medicine – facts and fiction
Hans Kress , Austria
Victoria Chapman , UK
Birgit Kraft , Austria
Flemming W. Bach , Denmark

Quantitative sensory testing (QST) in pain medicine: What is its value in clinical practice?
Oliver WilderSmith , The Netherlands
David Yarnitzky , Israel
Roman Rolke , Germany

Mechanisms and assessment of musculoskeletal pain
Anthony Jones , UK
Bruce Kidd , UK
Peter Croft , UK

TS11

Diet and other environmental influences on pain
Yoram Shir , Canada
William Rea , USA
Mark Ware , Canada

Cold receptors, cold transduction and cold pain
Felix Viana , Spain
Bernd Nilius , Belgium Ralf Baron , Germany
Carlos Belmonte
, Spain

Does chronic pain cause neuro­degeneration ?
Vania Apkarian , USA
TBA
TBA

TS12

Wiring and re-wiring of the dorsal horn
Juergen Sandkuhler , Austria   
Deolinda Lima , Portugal
Tony Dickenson , UK

Genetic analysis of neuropathic pain mechanisms
Ariel Darvasi , Israel
Peter Reeh
, Germany
Marshall Devor , Israel
Mathias Gebauer , Germany

Neuropathic pain in patients and animal models: are we looking at the same thing?
Ralf Baron , Germany
( Gary Bennett , Canada )
Susan Fleetwood-Walker , UK
Per Hansson , Sweden

TS13

Pain: philosophy and ethical dilemmas
Alex Cahana , Switzerland
Finn Nortvedt , Norway
Sadek Beloucif , France

Children and adolescents with chronic pain
Chris Eccleston , UK
Geert Crombez , Belgium
Christiane Hermann , Germany

Genetic polymorphisms associated with pain sensitivity
Andreas Zimmer , Germany
Zeev Seltzer , Canada
John Wood , UK

TS14

Pain measurement and control in the cognitively impaired and non-communicative
Ruth Defrin , Israel
Anne Hunt , UK
Ken Craig , Canada

How to change public p erception of
pain?
David Niv , Israel
Michael Zenz , Germany
Athena Vadalouca , Greece
( Giustino Varrassi , Italy )

17:30-18:15 Special Lectures (Plenary Session)

p4

Mechanisms of osteoarthritic and skeletal pain
Patrick Mantyh , USA

Neurobiology of addiction
Howard Fields , USA

Sex hormones, pregnancy, gender and pain
Roger Fillingim , USA

 

 

Abstract Submission Form

Free Presentations
www.kenes.com/efic/call.asp

 

For more information please contact:

European Federation of IASP Chapters (EFIC)
Ms. Sarah Wheeler
Executive Officer
E-mail: efic@internet.gr

or

Secretariat and Congress Organisers
EFIC 2006 Congress Secretariat
Kenes International
17 Rue du Cendrier, PO Box 1726
CH-1211, Geneva 1, Switzerland
Tel: +41 22 908 0488
Fax: +41 22 732 2850
E-mail: efic@kenes.com